Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT00901927
Status:
TERMINATED
Last Update Posted:
2020-04-03
First Post:
2009-05-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-12
First Submit QC Date:
None
Study First Post Date:
2009-05-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-05
Results First Submit QC Date:
None
Results First Post Date:
2020-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-01
Last Update Post Date:
2020-04-03
Last Update Post Date Type:
ACTUAL